Related content

Subcutaneous immunoglobulin administration: an alternative to intravenous infusion as adjuvant treatment for dermatomyositis?

By Schleinitz Nicolas   Jean Estelle   Benarous Lucas   Mazodier Karin   Figarella-Branger Dominique   Bernit Emmanuelle   Veit Véronique   Kaplanski Gilles   Harle Jean-Robert  

Clinical Rheumatology, Vol. 27, Iss. 8, 2008-08 ,pp. : 1067-1068

Springer Publishing Company

Access to resources Recommend Favorite

An Open-Label Extension Study of Alendronate Treatment in Elderly Women with Osteoporosis

By Downs   Jr. R. W.   Bone H. G.   McIlwain H.   Baker M. Z.   Yates A. J.   Lombardi A.   Krupa D.   Harning R.  

Calcified Tissue International, Vol. 64, Iss. 6, 1999-06 ,pp. : 463-469

Springer Publishing Company

Access to resources Recommend Favorite

Subcutaneous IgG in the Myositis Spectrum Disorders

By  

Current Rheumatology Reviews, Vol. 14, Iss. 3, 2018-11 ,pp. : 194-199

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis

By Vencovský J   Jarošová K   Macháček S   Studýnková J   Kafková J   Bartuňková J   Němcová D   Charvát F  

Scandinavian Journal of Rheumatology, Vol. 29, Iss. 2, 2000-05 ,pp. : 95-102

Informa Healthcare

Access to resources Recommend Favorite

An open-label study of administration of EH0202, a health-food additive, to patients with chronic hepatitis C

By Kaji Kyosuke   Yoshida Satoshi   Nagata Nobuo   Yamashita Tatsuya   Mizukoshi Eishiro   Honda Masao   Kojima Yasuhiko   Kaneko Shuichi  

Journal of Gastroenterology, Vol. 39, Iss. 9, 2004-09 ,pp. : 873-878

Springer Publishing Company

Access to resources Recommend Favorite